Provention Bio (NASDAQ:PRVB) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $0.55 by 183.64 percent. This is a 2.22 percent decrease over losses of $(0.45) per share from the same period last year.
BlockFi’s Credit Card Customers Are Up For Grabs, And Curve Is Determined To Get Them
Curve, a payments firm, is in talks to acquire cryptocurrency lender BlockFi's 87,000 credit card customers, whose credit cards were frozen on Nov. 11.
What Happened: According to a Curve spokesperson, negotiations between the two companies started on Nov. 12 and are still taking place.
